Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B — La Crosse, Wisconsin

Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B is a clinical research site located in La Crosse, Wisconsin, United States 54601.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Infections.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B?

Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B conducted?

Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B has 1 clinical trials on record. Their work covers Meningococcal Infections.

Is Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B accredited by Crixeo Health?

Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 92 - Gundersen Clinic, Ltd. 1836 South Ave.; Mailstop C03-006B?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.